Publikasjoner

  • Comprehensive ctDNA measurements improve prediction of clinical outcomes and enable dynamic tracking of disease progression in advanced pancreatic cancer. Lapin M, Edland KH, Tjensvoll K, Oltedal S, Austdal M, Garresori H, Rozenholc Y, Gilje B, Nordgård O. Clinical Cancer Research 2023 (online ahead of print).
  • Neoadjuvant chemotherapy is associated with an altered metabolic profile and increased cancer stemness in patients with pancreatic ductal adenocarcinoma. Amrutkar M, Verbeke CS, Finstadsveen AV, Dorg L, Labori KJ, Gladhaug IP. Molecular Oncology 2023;17:59-81.
  • Pancreatic stellate cell-induced gemcitabine resistance in pancreatic cancer is associated with LDHA- and MCT4-mediated enhanced glycolysis. Amrutkar M, Berg K, Balto A, Skilbrei MG, Finstadsveen AV, Aasrum M, Gladhaug IP, Verbeke CS. Cancer Cell International 2023;23: 9.
  • Proteome analysis of pancreatic tumors implicates extracellular matrix in patient outcome. Silwal-Pandit L, Stålberg SM, Johansson HJ, Mermelekas G, Lothe IMB, Skrede ML, Dalsgaard AM, Nebdal D, Helland Å, Lingjærde OC, Labori KJ, Skålhegg BS, Janne Lehtiö, Kure EH. Cancer Research Communications 2022;2:434-446.
  • The genetic risk factor CEL-HYB1 causes proteotoxicity and chronic pancreatitis in mice. Fjeld K, Gravdal A, Brekke RS, Alam J, Wilhelm SJ, El Jellas K, Pettersen HN, Lin J, Solheim MH, Steine SJ, Johansson BB, Njølstad PR, Verbeke CS, Xiao X, Lowe ME,  Molven A. Pancreatology 2022;22: 1099-1111.
  • C/EBPB-dependent adaptation to palmitic acid promotes tumor formation in hormone receptor negative breast cancer. Liu X-Z, Ruling A, Choi MH, Pedersen L, Lepland J, Takle ST, Madeleine N, Peters SD, Wogsland CE, Grøndal SM, Lorens JB, Goodarzi H, Lønning PE, Knappskog S, Molven A, Halberg N. Nature Communications 2022;13: 69.
  • Novel hybridization- and tag-based error-corrected method for sensitive ctDNA mutation detection using ion semiconductor sequencing. Tjensvoll K, Lapin M, Gilje B, Garresori H, Oltedal S, Forthun RB, Molven A, Rozenholc Y, Nordgård O. Scientific Reports 2022;12:1-10.
  • Prognostic value of disseminated tumor cells in unresectable PDAC: a prospective observational study. Nordgård O, Lapin M, Tjensvoll K, Oltedal S, Edland KH, Neverdahl NB, Fastens D, Garresori H, Glenn N, Smaaland R, Gilje B. BMC Cancer 2022;22:609.
  • KRAS mutation analysis by droplet digital PCR of duodenal juice from patients with MODY8 and other pancreatic diseases. Choi MH, Tjora E, Forthun ERB, Engjom T, Ræder H, Hovland R, Molven A. Pancreatology 2021;21:1460-1465.
  • Morphological heterogeneity in pancreatic cancer reflects structural and functional divergence. Santha P, Lenggenhager D, Finstadsveen A, Dorg L, Tøndel K, Amrutkar M, Gladhaug IP, Verbeke C. Cancers 2021;12:895.
Publisert 16. mars 2021 17:17 - Sist endret 24. feb. 2023 16:13